Cite
Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma
MLA
Elizabeth Challenger, et al. “Development and Validation of an LC-MS/MS Method for Quantification of Favipiravir in Human Plasma.” Journal of Pharmaceutical and Biomedical Analysis, vol. 233, Sept. 2023, p. 115436. EBSCOhost, https://doi.org/10.1016/j.jpba.2023.115436.
APA
Elizabeth Challenger, Sujan Dilly Penchala, Colin Hale, Richard Fitzgerald, Lauren Walker, Helen Reynolds, Justin Chiong, Tom Fletcher, Saye Khoo, & Laura Else. (2023). Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma. Journal of Pharmaceutical and Biomedical Analysis, 233, 115436. https://doi.org/10.1016/j.jpba.2023.115436
Chicago
Elizabeth Challenger, Sujan Dilly Penchala, Colin Hale, Richard Fitzgerald, Lauren Walker, Helen Reynolds, Justin Chiong, Tom Fletcher, Saye Khoo, and Laura Else. 2023. “Development and Validation of an LC-MS/MS Method for Quantification of Favipiravir in Human Plasma.” Journal of Pharmaceutical and Biomedical Analysis 233 (September): 115436. doi:10.1016/j.jpba.2023.115436.